首页> 外文期刊>Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis >Comparison of three prognostic scoring systems in a series of 146 cases of chronic myelomonocytic leukemia (CMML): MD Anderson prognostic score (MDAPS), CMML-specific prognostic scoring system (CPSS) and Mayo prognostic model. A detailed review of prognostic factors in CMML
【24h】

Comparison of three prognostic scoring systems in a series of 146 cases of chronic myelomonocytic leukemia (CMML): MD Anderson prognostic score (MDAPS), CMML-specific prognostic scoring system (CPSS) and Mayo prognostic model. A detailed review of prognostic factors in CMML

机译:在一系列146例慢性粒细胞单核细胞白血病(CMML)中的三种预后评分系统的比较:MD安德森预后评分(MDAPS),特定于CMML的预后评分系统(CPSS)和Mayo预后模型。 CMML预后因素的详细审查

获取原文
获取原文并翻译 | 示例
           

摘要

Although specific prognostic models for chronic myelomonocytic leukemia (CMML) exist, few are based on large series of patients. MD Anderson prognostic score (MDAPS) has been the most useful for CMML risk assessment. Due to recent emergence of CMML-specific prognostic scoring system (CPSS) and Mayo prognostic model, we compared the three scores.
机译:尽管存在慢性粒细胞单核细胞白血病(CMML)的特定预后模型,但很少有基于大量患者的模型。 MD Anderson的预后评分(MDAPS)对于CMML风险评估最有用。由于最近出现了针对CMML的预后评分系统(CPSS)和Mayo预后模型,我们比较了这三个评分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号